Synergistic effects of atorvastatin and sildenafil in cardioprotection--role of NO.
Kukreja
Rakesh C
RC
D000818:Animals; D000069059:Atorvastatin; D002316:Cardiotonic Agents / Q000627:therapeutic use*; D004357:Drug Synergism; D006538:Heptanoic Acids / Q000627:therapeutic use*; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000627:therapeutic use*; D015428:Myocardial Reperfusion Injury / Q000378:metabolism / Q000517:prevention & control*; D009569:Nitric Oxide / Q000378:metabolism*; D010726:Phosphodiesterase Inhibitors / Q000627:therapeutic use*; D010879:Piperazines / Q000627:therapeutic use*; D011687:Purines; D011758:Pyrroles / Q000627:therapeutic use*; D000068677:Sildenafil Citrate; D013450:Sulfones
D002316:Cardiotonic Agents; D006538:Heptanoic Acids; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors; D010726:Phosphodiesterase Inhibitors; D010879:Piperazines; D011687:Purines; D011758:Pyrroles; D013450:Sulfones; D009569:Nitric Oxide; D000069059:Atorvastatin; D000068677:Sildenafil Citrate